Concepts (92)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hippocampus | 5 | 2015 | 73 | 1.090 |
Why?
|
| Neurons | 4 | 2017 | 131 | 0.980 |
Why?
|
| Alzheimer Disease | 3 | 2016 | 90 | 0.930 |
Why?
|
| Brain Injuries, Traumatic | 2 | 2017 | 45 | 0.720 |
Why?
|
| Glutamic Acid | 3 | 2017 | 5 | 0.700 |
Why?
|
| Epilepsy | 2 | 2015 | 34 | 0.650 |
Why?
|
| Brain | 2 | 2019 | 286 | 0.630 |
Why?
|
| Neural Pathways | 2 | 2015 | 41 | 0.540 |
Why?
|
| Interneurons | 3 | 2016 | 6 | 0.520 |
Why?
|
| Excitatory Postsynaptic Potentials | 2 | 2014 | 6 | 0.430 |
Why?
|
| Entorhinal Cortex | 1 | 2013 | 4 | 0.430 |
Why?
|
| Animals | 10 | 2017 | 1817 | 0.420 |
Why?
|
| Long-Term Synaptic Depression | 1 | 2009 | 1 | 0.330 |
Why?
|
| Long-Term Potentiation | 1 | 2009 | 5 | 0.330 |
Why?
|
| Geniculate Bodies | 1 | 2009 | 3 | 0.330 |
Why?
|
| Synapses | 1 | 2009 | 13 | 0.330 |
Why?
|
| Rats | 6 | 2017 | 251 | 0.320 |
Why?
|
| Seizures | 2 | 2014 | 33 | 0.310 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2019 | 73 | 0.310 |
Why?
|
| Retina | 1 | 2009 | 130 | 0.290 |
Why?
|
| Cortical Spreading Depression | 1 | 2017 | 1 | 0.280 |
Why?
|
| Models, Neurological | 1 | 2017 | 44 | 0.270 |
Why?
|
| Nerve Net | 2 | 2014 | 46 | 0.270 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2017 | 131 | 0.260 |
Why?
|
| In Vitro Techniques | 3 | 2017 | 16 | 0.230 |
Why?
|
| Action Potentials | 2 | 2016 | 28 | 0.230 |
Why?
|
| Adenosine | 1 | 2014 | 1 | 0.230 |
Why?
|
| Purinergic P1 Receptor Agonists | 1 | 2014 | 1 | 0.230 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2014 | 2 | 0.230 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2012 | 1 | 0.210 |
Why?
|
| Biological Clocks | 1 | 2012 | 9 | 0.200 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2012 | 8 | 0.200 |
Why?
|
| Ion Channels | 2 | 2017 | 6 | 0.200 |
Why?
|
| Neuronal Plasticity | 1 | 2012 | 21 | 0.200 |
Why?
|
| Age Factors | 2 | 2013 | 75 | 0.190 |
Why?
|
| Voltage-Sensitive Dye Imaging | 2 | 2017 | 4 | 0.180 |
Why?
|
| Membrane Potentials | 3 | 2017 | 16 | 0.180 |
Why?
|
| Mice | 3 | 2016 | 719 | 0.160 |
Why?
|
| Cell Size | 2 | 2019 | 6 | 0.150 |
Why?
|
| Aspartic Acid | 2 | 2017 | 2 | 0.140 |
Why?
|
| Electrophysiological Phenomena | 2 | 2017 | 10 | 0.140 |
Why?
|
| Astrocytes | 2 | 2017 | 16 | 0.140 |
Why?
|
| Patch-Clamp Techniques | 2 | 2016 | 19 | 0.140 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2015 | 4 | 0.120 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2015 | 6 | 0.120 |
Why?
|
| tau Proteins | 1 | 2015 | 9 | 0.120 |
Why?
|
| Thalamus | 1 | 2015 | 7 | 0.120 |
Why?
|
| Cerebral Cortex | 1 | 2015 | 53 | 0.120 |
Why?
|
| Male | 4 | 2017 | 2770 | 0.120 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2014 | 8 | 0.110 |
Why?
|
| Oxygen | 1 | 2014 | 21 | 0.110 |
Why?
|
| Evoked Potentials | 1 | 2013 | 29 | 0.100 |
Why?
|
| Nimodipine | 1 | 2009 | 1 | 0.080 |
Why?
|
| 2-Amino-5-phosphonovalerate | 1 | 2009 | 1 | 0.080 |
Why?
|
| GABA Antagonists | 1 | 2009 | 1 | 0.080 |
Why?
|
| Nitrendipine | 1 | 2009 | 2 | 0.080 |
Why?
|
| Bicuculline | 1 | 2009 | 3 | 0.080 |
Why?
|
| Calcium Channel Blockers | 1 | 2009 | 4 | 0.080 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2009 | 7 | 0.080 |
Why?
|
| Biophysics | 1 | 2009 | 16 | 0.080 |
Why?
|
| Rats, Long-Evans | 1 | 2009 | 19 | 0.080 |
Why?
|
| Animals, Newborn | 1 | 2009 | 37 | 0.080 |
Why?
|
| Electric Stimulation | 1 | 2009 | 24 | 0.080 |
Why?
|
| Visual Pathways | 1 | 2009 | 19 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 53 | 0.080 |
Why?
|
| Pyramidal Cells | 2 | 2014 | 2 | 0.080 |
Why?
|
| Monte Carlo Method | 1 | 2019 | 17 | 0.080 |
Why?
|
| Software | 1 | 2019 | 59 | 0.080 |
Why?
|
| Time Factors | 1 | 2009 | 176 | 0.080 |
Why?
|
| Female | 2 | 2016 | 2816 | 0.070 |
Why?
|
| Receptors, AMPA | 1 | 2017 | 3 | 0.070 |
Why?
|
| Brain Diseases | 1 | 2017 | 4 | 0.070 |
Why?
|
| N-Methylaspartate | 1 | 2017 | 9 | 0.070 |
Why?
|
| Homeostasis | 1 | 2017 | 30 | 0.070 |
Why?
|
| Visual Cortex | 1 | 2017 | 24 | 0.070 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2017 | 2 | 0.070 |
Why?
|
| Sodium Channels | 1 | 2017 | 5 | 0.070 |
Why?
|
| Computational Biology | 1 | 2017 | 42 | 0.070 |
Why?
|
| Biological Transport | 1 | 2017 | 19 | 0.070 |
Why?
|
| Algorithms | 1 | 2019 | 275 | 0.070 |
Why?
|
| Humans | 2 | 2016 | 5485 | 0.060 |
Why?
|
| NAV1.1 Voltage-Gated Sodium Channel | 1 | 2014 | 2 | 0.060 |
Why?
|
| Organ Culture Techniques | 1 | 2014 | 4 | 0.060 |
Why?
|
| Mice, 129 Strain | 1 | 2014 | 3 | 0.060 |
Why?
|
| Gene Knock-In Techniques | 1 | 2014 | 11 | 0.060 |
Why?
|
| 4-Aminopyridine | 1 | 2012 | 1 | 0.050 |
Why?
|
| Potassium Channel Blockers | 1 | 2012 | 2 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 195 | 0.050 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2016 | 2 | 0.030 |
Why?
|
| Sodium | 1 | 2016 | 13 | 0.030 |
Why?
|
| Amyloid beta-Peptides | 1 | 2016 | 18 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2016 | 50 | 0.030 |
Why?
|